Generating Biologics to Modulate IFITM1 in Cancer and Infection - Modulating Immune Signalling Pathways for patient Benefit in Cancer

Project Details

StatusFinished
Effective start/end date1/09/17 → 31/03/22

Funding

  • Scotia Biologics Limited: £10,000.00